Literature DB >> 9556469

The Eisenmenger syndrome in adults.

W Vongpatanasin1, M E Brickner, L D Hillis, R A Lange.   

Abstract

For this article, the literature on the pathophysiology, clinical features, natural history, prognosis, and management of the Eisenmenger syndrome in adults was reviewed. English-language articles from 1966 to the present were identified through a search of the MEDLINE database by using the terms Eisenmenger, congenital heart disease, and pulmonary hypertension. Selected cross-referenced articles were also included. Articles on the pathophysiology, clinical presentation, evaluation, natural history, complications, and treatment of the Eisenmenger syndrome in adults were selected, and descriptive and analytical data relevant to the practicing physician were manually extracted. The Eisenmenger syndrome is characterized by elevated pulmonary vascular resistance and right-to-left shunting of blood through a systemic-to-pulmonary circulation connection. Most patients with the syndrome survive for 20 to 30 years. The hemostatic changes associated with the syndrome may lead to thromboembolic events, cerebrovascular complications, or the hyperviscosity syndrome. Erythrocytosis is present in most patients, but excessive phlebotomy may cause microcytosis and exacerbate the symptoms of hyperviscosity. Other complications associated with the Eisenmenger syndrome include hemoptysis, gout, cholelithiasis, hypertrophic osteoarthropathy, and decreased renal function. Pregnancy or noncardiac surgery is associated with a high mortality rate in patients with the Eisenmenger syndrome. Because most pediatric patients with the Eisenmenger syndrome survive to adulthood, primary care physicians should have a thorough understanding of the syndrome; its associated complications; and medical and surgical management, especially with regard to the appropriate timing of phlebotomy and lung or heart-lung transplantation. In addition, patients with the syndrome should undergo routine follow-up at a tertiary care center that has physicians and nurses with special expertise in congenital heart disease. In patients with the Eisenmenger syndrome who are pregnant or require noncardiac surgery, a multidisciplinary approach should be used to reduce the excessive mortality associated with these conditions.

Entities:  

Mesh:

Year:  1998        PMID: 9556469     DOI: 10.7326/0003-4819-128-9-199805010-00008

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  44 in total

1.  Eisenmenger's Syndrome.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  1999-12

Review 2.  Epidemiology of pulmonary arterial hypertension.

Authors:  Xin Jiang; Zhi-Cheng Jing
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

Review 3.  Novel Insights and Treatment Strategies for Right Heart Failure.

Authors:  Weiqin Lin; Ai-Ling Poh; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2018-06

Review 4.  The changing epidemiology of congenital heart disease.

Authors:  Teun van der Bom; A Carla Zomer; Aeilko H Zwinderman; Folkert J Meijboom; Berto J Bouma; Barbara J M Mulder
Journal:  Nat Rev Cardiol       Date:  2010-11-02       Impact factor: 32.419

5.  A prediction model of simple echocardiographic variables to screen for potentially correctable shunts in adult patients with pulmonary arterial hypertension associated with atrial septal defects: a cross-sectional study.

Authors:  Mingqi Li; Yu Wang; Hezhi Li; Yigao Huang; Tao Huang; Caojin Zhang; Hongwen Fei
Journal:  Int J Cardiovasc Imaging       Date:  2021-02-02       Impact factor: 2.357

6.  Dental considerations and recommendations in Eisenmenger syndrome: A report of an unusual paediatric case.

Authors:  P A Calderón-Ávila; J A Garrocho-Rangel; J A Cepeda-Bravo; M S Ruiz-Rodríguez; M Pierdant-Pérez; A Pozos-Guillén
Journal:  Eur Arch Paediatr Dent       Date:  2018-09-08

7.  Pregnancy in patients with heart disease: experience with 1,000 cases.

Authors:  Walkiria Samuel Avila; Eduardo Giusti Rossi; José Antonio Franchini Ramires; Max Grinberg; Maria Rita Lemos Bortolotto; Marcelo Zugaib; Protasio Lemos da Luz
Journal:  Clin Cardiol       Date:  2003-03       Impact factor: 2.882

8.  Effect of bosentan therapy on ventricular and atrial function in adults with Eisenmenger syndrome. A prospective, multicenter study using conventional and Speckle tracking echocardiography.

Authors:  Mohamed Y Abd El Rahman; Axel Rentzsch; Philipp Scherber; Siegrun Mebus; Oliver Miera; Günther Balling; Petra Böttler; Karl-Otto Dubowy; Birgit Farahwaschy; Alfred Hager; Joachim Kreuder; Brigitte Peters; Felix Berger; Ingram Schulze-Neick; Hashim Abdul-Khaliq
Journal:  Clin Res Cardiol       Date:  2014-03-30       Impact factor: 5.460

Review 9.  Blue babies: when to intervene.

Authors:  Savitri Shrivastava
Journal:  Indian J Pediatr       Date:  2005-07       Impact factor: 1.967

10.  Anaesthetic management of hip arthroplasty in an individual with trisomy 21 and Eisenmenger's syndrome.

Authors:  Joanna M Bilak; John Saddler
Journal:  BMJ Case Rep       Date:  2013-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.